报道提到，赫卡比在一份长达七页的伦理协议中向美国联邦政府道德办公室表示，已授权该品牌使用其 姓名和肖像权。在担任大使期间，他不会签署任何新的授权协议，但将继续从之前的授权协议中获得报 酬。赫卡比披露的财务数据显示，该产品生产方在赫卡比被提名为美国驻以色列大使的前一年（2024 年），向其支付了414684美元的代言费。 报道称，就在NOTUS发布相关报道后不久，该产品生产方似乎从其网站上删除了赫卡比的视频。 NOTUS报道称，赫卡比在深夜播出的美国电视广告中推销一种助眠补剂。在广告中，赫卡比称他信任 该产品，并引导观众进行购买。 《独立报》称，赫卡比多年来一直担任该产品的付费代言人。即便在担任政府要职期间，他似乎仍然从 中获利，没有放弃这份工作的打算。 【环球网报道 记者 张倩】英国《独立报》、以色列国家新闻网等媒体援引NOTUS新闻网站25日消息报 道称，美国驻以色列大使迈克·赫卡比被爆在职期间担任某助眠补剂产品的付费代言人，引发了外界关 于潜在伦理问题的质疑。 当被问及赫卡比是否担心相关代言与其政府工作冲突时，美国驻以色列大使馆表示，"不。大使也需要 睡觉。" ...

Core Viewpoint - The article discusses the controversial trend in Silicon Valley where elite individuals are using genetic screening technologies to select embryos based on desirable traits, including intelligence, leading to ethical concerns about eugenics and societal implications [4][14]. Group 1: Genetic Screening Technologies - The article outlines various genetic screening technologies, including PGT-M for single-gene disorders, PGT-A for aneuploidy, PGT-SR for chromosomal structural abnormalities, and PGT-P for polygenic disease risk assessment [6][8]. - PGT-P technology, which allows for the prediction of complex traits such as intelligence and physical appearance, has gained traction since the birth of the first baby using this method in 2020 [8][9]. Group 2: Emergence of Companies - Companies like Orchid and Herasight are at the forefront of offering embryo selection services based on intelligence, with claims of detecting IQ differences of up to 15 points among embryos [11][12]. - Nucleus Genomics has created a "gene store" where prospective parents can select from over 2,000 traits, including disease resistance and personality characteristics, raising ethical questions about commodifying human life [12][13]. Group 3: Ethical Implications - The article raises concerns about the potential societal impact of genetic selection, suggesting that if society begins to view genetic endowment as a determinant of personal ability and destiny, it could lead to a collapse of existing value systems [14][16]. - The narrative draws parallels to the film "Gattaca," which depicts a future where genetic selection creates a divide between the genetically elite and the underprivileged, emphasizing the risks of unchecked genetic engineering [13][14].